Physician profile
Robert Wolf
NPI 1912974932
$2,978.37
in general payments reported to CMS, 2019-2025
9 companies · $370 in 2025
The $370 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $445 · 2020: $51.05 · 2021: $818 · 2022: $447 · 2023: $359 · 2024: $489 · 2025: $370.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,130 · Long Term Medical Supply Or Device Loan: $87.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,129.82 |
| Long Term Medical Supply Or Device Loan | $87.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,176.40 | 2019-2025 | Mako, T2 Alpha, Accolade |
| Corentec America INC | $215.00 | 2025 | Corentec |
| Sanara Medtech INC. | $175.84 | 2024 | Celleraterx |
| Next Science LLC | $130.36 | 2021 | |
| Zimmer Biomet Holdings, INC. | $129.60 | 2019 | |
| Integra Lifesciences Corporation | $87.45 | 2024 | Acell |
| Pylant Medical | $26.67 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $20.82 | 2024 | Exparel |
| Smith+Nephew, INC. | $16.23 | 2024 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Wolf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.